Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ampio rises on plans for second version of Zertane
Yahoo/AP
Monday, July 2, 2012 - 12:28pm
tags:
Ampio, Zertane, impotence, premature ejaculation
J&J seeks OK for first drug against resistant TB
Yahoo/AP
Monday, July 2, 2012 - 12:25pm
tags:
JNJ, tuberculosis, bedaquiline, Janssen
Pfizer's New Drug Failure Only Minor Setback
Motley Fool
Monday, July 2, 2012 - 12:20pm
tags:
Pfizer, tafamidis meglumine, TTR-FAP
Glaxo to pay $3 bln to settle U.S. fraud charges
Marketwatch
Monday, July 2, 2012 - 11:27am
tags:
whistleblower lawsuits, fraud, GSK
GSK hails positive results for combo new lung drug
Reuters
Monday, July 2, 2012 - 10:46am
tags:
GSK, Theravance, LAMA/LABA, COPD
Abbott Will Jump On 3 Big Assets
Seeking Alpha
Monday, July 2, 2012 - 10:43am
tags:
Abbott Laboratories, Merck, Pfizer, JNJ, GSK
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Monday, July 2, 2012 - 10:42am
tags:
Eli Lilly, diabetes, Bristol-Myers Squibb, Incyte, Merck, Sanofi, Novo Nordisk
Bristol-Myers acquisition a good strategic fit, says Deutsche Bank
Yahoo/Fly on the Wall
Monday, July 2, 2012 - 10:41am
tags:
Amylin, M&A, Bristol-Myers Squibb
Medicines Co expects Cangrelor Phase 3 trial enrollment completion in 2012
Yahoo/Fly on the Wall
Monday, July 2, 2012 - 10:40am
tags:
Cangrelor, Medicines Company
Gaucher Disease: The Fight For Market Share
Seeking Alpha
Sunday, July 1, 2012 - 12:12pm
tags:
Gaucher disease
Valeant: Buy This 'Spring Loaded' Stock Now
Seeking Alpha
Sunday, July 1, 2012 - 12:11pm
tags:
Valeant Pharmaceuticals
A Promising $5 Biotech Stock With Major Insider Buying
Seeking Alpha
Sunday, July 1, 2012 - 12:07pm
tags:
Amicus Therapeutics
2 Pharma Plays Trading Under $2 For The Aggressive Investor
Seeking Alpha
Sunday, July 1, 2012 - 12:05pm
tags:
Pluristem Therapeutics, PharmAthene
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
Pipeline Review
Saturday, June 30, 2012 - 4:41pm
tags:
Teva Pharmaceuticals, neutropenia, breast cancer, lipegfilgrastim, balugrastim
Salix Pharma: What's The Buzz?
RTT News
Saturday, June 30, 2012 - 4:38pm
tags:
Salix
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Pharmabiz
Saturday, June 30, 2012 - 4:35pm
tags:
MLN9708, Multiple Myeloma, Millennium
Noven Pharmaceuticals provides update on status of generic Lidoderm ANDA
news-medical.net
Saturday, June 30, 2012 - 4:33pm
tags:
Noven, lidoderm, generics
Biogen Idec Inc. and Isis Pharmaceuticals Inc. to Work Together in a Project
French Tribune, France
Saturday, June 30, 2012 - 4:32pm
tags:
Biogen Idec, Isis Pharmaceuticals, muscular dystrophy
K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria
MarketWatch
Saturday, June 30, 2012 - 4:31pm
tags:
KV Pharmaceutical
Why Biotechs Arena And Vivus Will Grow While People Shrink
Seeking Alpha
Saturday, June 30, 2012 - 4:11pm
tags:
Arena, Vivus, obesity, weight loss, Qnexa, lorcaserin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.